BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5331452)

  • 1. Sensitivity of Mycobacterium leprae to low levels of 4,4'-diaminodiphenyl sulfone.
    Shepard CC; McRae DH; Habas JA
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):893-6. PubMed ID: 5331452
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 3. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
    Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
    Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
    [No Abstract]   [Full Text] [Related]  

  • 5. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
    Levy L; Peters JH
    Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress in leprosy research.
    WHO Chron; 1966 Mar; 20(3):98-100. PubMed ID: 5325357
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
    Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
    Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone-resistant leprosy in Jakarta: a preliminary report.
    Utji R; Kosasih A; Santoso AU
    Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723
    [No Abstract]   [Full Text] [Related]  

  • 10. Dapsone-resistant leprosy in Ethiopia.
    Pearson JM; Haile GS; Barnetson RS; Rees RJ
    Lepr Rev; 1979 Sep; 50(3):183-99. PubMed ID: 392212
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
    Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
    Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
    Pattyn SR; Yada A; Sansarricq H; van Loo L
    Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of leprosy today and tomorrow: the LEPRA consultation on chemotherapy.
    Browne SG
    Lepr Rev; 1977 Dec; 48(4):283-6. PubMed ID: 400810
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary dapsone resistance in leprosy.
    Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
    Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
    Millan J; Moulia-Pelat JP
    Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone-resistant leprosy in a population of Bamako (Mali).
    Baquillon G; Ferracci C; Saint Andre P; Pattyn SR
    Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug susceptibility testing of Mycobacterium leprae.
    Baohong J
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.